|
|
|
|
Vol. 61, Issue 1, 127-135, January 2002
4
2 Neuronal Nicotinic Acetylcholine
Receptor by Estradiol
Department of Physiology, Faculty of Medicine, Genève,
Switzerland
The modulation of neurotransmitter receptors by various substances can
reflect important physiological mechanisms involved in the regulation
of neural function. Furthermore, such substances, in particular
specific allosteric modulators, can reveal promising therapeutic
targets for diseases of the nervous system. From this perspective, we
investigated the effects of the steroid hormone estradiol on human
neuronal nicotinic acetylcholine receptors expressed either in
Xenopus laevis oocytes or human embryonic kidney cells.
Acetylcholine-evoked currents were potentiated both by pre- and
coapplications of estradiol in
4
2 and
4
4 receptors, but not
in
3
2 or
3
4 receptors. The reversible potentiation of
4-containing receptors could be induced within seconds in X.
laevis oocytes and at micromolar concentrations of estradiol. The potentiation was greatest for responses evoked by low
concentrations of acetylcholine, resulting in an apparent increase of
receptor affinity. At the single channel level, estradiol potentiation resulted from an increase in opening probability. Finally, the use of
functional chimeric or truncated
4 subunits demonstrated that a site
at the C-terminal tail of the
4 subunit is required for estradiol
potentiation. These results suggest the presence of a specific site at
the human nicotinic acetylcholine receptor
4 subunit through which
estradiol can cause an allosteric potentiation of acetylcholine-evoked responses.
This article has been cited by other articles:
![]() |
K. P. Cosgrove, E. M. Mitsis, F. Bois, E. Frohlich, G. D. Tamagnan, E. Krantzler, E. Perry, P. K. Maciejewski, C. N. Epperson, S. Allen, et al. 123I-5-IA-85380 SPECT Imaging of Nicotinic Acetylcholine Receptor Availability in Nonsmokers: Effects of Sex and Menstrual Phase J. Nucl. Med., October 1, 2007; 48(10): 1633 - 1640. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Broad, R. Zwart, K. H. Pearson, M. Lee, L. Wallace, G. I. McPhie, R. Emkey, S. P. Hollinshead, C. P. Dell, S. R. Baker, et al. Identification and Pharmacological Profile of a New Class of Selective Nicotinic Acetylcholine Receptor Potentiators J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1108 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Briggs, E. J. Gubbins, M. J. Marks, C. B. Putman, R. Thimmapaya, M. D. Meyer, and C. S. Surowy Untranslated Region-Dependent Exclusive Expression of High-Sensitivity Subforms of {alpha}4beta2 and {alpha}3beta2 Nicotinic Acetylcholine Receptors Mol. Pharmacol., July 1, 2006; 70(1): 227 - 240. [Abstract] [Full Text] [PDF] |
||||